Sophie Rose is an infectious disease epidemiology fellow at Johns Hopkins Bloomberg School of Public Health. Alongside cofounder Josh Morrison, she established 1Day Sooner, an organization that advocates for human challenge trial volunteers. Her work focuses on systematically evaluating and advocating for the implementation of strategies that will accelerate COVID-19 vaccine development and distribution.
For much of 2020, this involved working alongside stakeholders such as the University of Oxford's Jenner Institute, government working groups and leading experts to ensure COVID-19 human challenge trials could be preserved as an option should a time come when they were approved for use. 1Day Sooner continues to educate the public about challenge trials and their potential impact on the vaccine landscape. They were the recipient of Emergent Ventures anti-COVID-19 prize and have been awarded funding from a number of philanthropic organizations, including The David and Lucile Packard Foundation.
Rose is focusing her career on analyzing global biological risks in the context of public health priority setting and pandemic preparedness in the hope of building a world where pandemics are a thing of the past.
In this moment of great uncertainty, it’s time to be fearless. TEDWomen 2020, a day-long event hosted on TED’s virtual event platform, is all about fearlessness — in the way we think, act, participate — and how this collective mentality can empower us to take a global step forward, together. The day kicked off with […]
Continue readingTEDWomen 2020 is nearly here! The day-long conference will take place on November 12 via TED’s new virtual conference platform. TEDWomen attendees will experience TED’s signature talks as well as an array of live, interactive sessions, community “idea dates,” small-group speaker Q&As and more. The talks featured in the program have been developed in collaboration […]
Continue reading